Couñago Lorenzo, FelipeRodríguez de Dios, NuriaMontemuiño, SaraJové Teixidó, JosepMartín, MargaritaCalvo Crespo, PatriciaLópez Mata, MiriamThuissard Vasallo, Israel JohnSanz Rosa, DavidTaboada, BegoñaEt al.2018-12-132018-12-132018Couñago, F., de Dios, N. R., Montemuiño, S., Jové-Teixidó, J., Martin, M., Calvo-Crespo, P., ... & Díaz-Díaz, V. (2018). Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC-ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav. Lung Cancer (Amsterdam, Netherlands), 123, 174. https://doi.org/10.1016/j.lungcan.2018.06.0310169-5002http://hdl.handle.net/11268/7690We wish to thank Jeremic and colleagues for commenting on our recent article [1]. As those authors observed in their comment, our study has several limitations (all of which were described in the article) related to the retrospective design. While we appreciate the feedback provided by those authors, we would like to clarify several points raised in their letter...engResponse to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislavjournal article0.1016/j.lungcan.2018.06.031restricted accessCáncerCáncer